EP2981624
METHODS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY AND PREDICTING RESPONSE TO CANCER TREATMENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.4.2014EP published:
18.12.2019EP application number:
14779403.6
EPO information:
European Patent Register
Max expiry date:
3.4.2034
Title:
METHODS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY AND PREDICTING RESPONSE TO CANCER TREATMENT
Timeline
Today
4.4.2014EP application
18.12.2019EP Publication
Owner
Name:
Myriad Genetics, Inc.Address:
320 Wakara Way, Salt Lake City, UT 84108, US
Inventor
Name:
ABKEVICH, VictorAddress:
Salt Lake City Utah 84108, US
Name:
TIMMS, KirstenAddress:
Salt Lake City Utah 84108, US
Name:
GUTIN, AlexanderAddress:
Salt Lake City Utah 84108, US
Priority
Number:
201361809105 PDate:
5.4.2013Country:
US
Number:
201361913762 PDate:
9.12.2013Country:
US
Classification
Categories:
C12Q 1/6886